FI963509A0 - Isoksatsoliiniyhdisteitä 5-lipoksigenaasi-inhibiittoreina - Google Patents

Isoksatsoliiniyhdisteitä 5-lipoksigenaasi-inhibiittoreina

Info

Publication number
FI963509A0
FI963509A0 FI963509A FI963509A FI963509A0 FI 963509 A0 FI963509 A0 FI 963509A0 FI 963509 A FI963509 A FI 963509A FI 963509 A FI963509 A FI 963509A FI 963509 A0 FI963509 A0 FI 963509A0
Authority
FI
Finland
Prior art keywords
lipoxygenase inhibitors
isoxazoline compounds
isoxazoline
compounds
lipoxygenase
Prior art date
Application number
FI963509A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI963509A (fi
Inventor
Victoria L Cohan
Edward F Kleinman
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI963509A0 publication Critical patent/FI963509A0/fi
Publication of FI963509A publication Critical patent/FI963509A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI963509A 1994-03-09 1996-09-06 Isoksatsoliiniyhdisteitä 5-lipoksigenaasi-inhibiittoreina FI963509A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20876894A 1994-03-09 1994-03-09
PCT/IB1995/000041 WO1995024192A1 (en) 1994-03-09 1995-01-19 Isoxazoline compounds as 5-lipoxygenase inhibitors

Publications (2)

Publication Number Publication Date
FI963509A0 true FI963509A0 (fi) 1996-09-06
FI963509A FI963509A (fi) 1996-09-06

Family

ID=22775981

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963509A FI963509A (fi) 1994-03-09 1996-09-06 Isoksatsoliiniyhdisteitä 5-lipoksigenaasi-inhibiittoreina

Country Status (11)

Country Link
US (1) US5696141A (ja)
EP (1) EP0749307A1 (ja)
JP (1) JPH09505081A (ja)
AU (1) AU1326795A (ja)
CA (1) CA2184914C (ja)
FI (1) FI963509A (ja)
IL (1) IL112849A (ja)
MX (1) MX9603943A (ja)
MY (1) MY112586A (ja)
WO (1) WO1995024192A1 (ja)
ZA (1) ZA951911B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2424521A4 (en) 2009-04-29 2015-03-04 Amarin Pharmaceuticals Ie Ltd PHARMACEUTICAL COMPOSITIONS COMPRISING EPA AND CARDIOVASCULAR AGENT AND METHODS OF USE

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62103070A (ja) * 1985-10-29 1987-05-13 Mitsui Toatsu Chem Inc イソオキサゾリン誘導体および植物生長調節剤
WO1987006576A1 (en) * 1986-04-29 1987-11-05 Pfizer Inc. Calcium independent camp phosphodiesterase inhibitor antidepressant
IE59813B1 (en) * 1986-05-09 1994-04-06 Warner Lambert Co Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them
US4731382A (en) * 1986-12-29 1988-03-15 Bristol-Myers Company Lipoxygenase inhibitory phenylalkanohydroxamic acids
FR2639636B1 (fr) * 1988-11-30 1994-03-04 Novapharme Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant
IL92915A0 (en) * 1989-01-05 1990-09-17 Ciba Geigy Ag Certain pyrrolylphenyl-substituted hydroxamic acid derivatives
CA2017383A1 (en) * 1989-06-08 1990-12-08 Raymond R. Martodam Use of vanilloids for the treatment of respiratory diseases or disorders
WO1991007177A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
DE3939010A1 (de) * 1989-11-25 1991-05-29 Hoechst Ag Isoxazoline, verfahren zu ihrer herstellung und ihre verwendung als pflanzenschuetzende mittel
JP2787602B2 (ja) * 1990-01-24 1998-08-20 大鵬薬品工業株式会社 イソキサゾリン誘導体
US5234937A (en) * 1990-03-27 1993-08-10 Warner-Lambert Company 3,5-di-tertiary-butyl-4-hydroxphenyl oxazolyl methanones and related compounds as antiinflammatory agents
GB9007762D0 (en) * 1990-04-05 1990-06-06 Beecham Group Plc Novel compounds
CA2095429A1 (en) * 1990-11-06 1992-05-07 Paul E. Bender Imidazolidinone compounds
PT100441A (pt) * 1991-05-02 1993-09-30 Smithkline Beecham Corp Pirrolidinonas, seu processo de preparacao, composicoes farmaceuticas que as contem e uso
US5140047A (en) * 1991-05-03 1992-08-18 Smithkline Beecham Corporation Lipoxygenase inhibitors
GB9215921D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Anti-inflammatory compounds
US5288397A (en) * 1992-09-18 1994-02-22 Mobil Oil Corporation Baffled FCC regeneration process and apparatus
WO1994018158A1 (en) * 1993-02-15 1994-08-18 Pfizer Inc. Spiroalkylhydroxyureas for use as lipoxygenase inhibitors

Also Published As

Publication number Publication date
EP0749307A1 (en) 1996-12-27
CA2184914A1 (en) 1995-09-14
MY112586A (en) 2001-07-31
AU1326795A (en) 1995-09-25
CA2184914C (en) 2000-09-19
ZA951911B (en) 1996-09-09
US5696141A (en) 1997-12-09
JPH09505081A (ja) 1997-05-20
IL112849A0 (en) 1995-06-29
FI963509A (fi) 1996-09-06
MX9603943A (es) 1997-04-30
WO1995024192A1 (en) 1995-09-14
IL112849A (en) 1999-04-11

Similar Documents

Publication Publication Date Title
DK0777671T3 (da) Spiro-azabicykliske forbindelser
FI963597A (fi) Isoprenyylitransferaasi-inhibiittoreita
NO972930D0 (no) Fibronectin-adhesjonsinhibitorer
ID19609A (id) Senyawa-senyawa heterosiklik
FI972160A (fi) Matriisimetalloproteaasi-inhibiittorit
DE69716924T2 (de) Phosphonat-nukleotid-verbindungen
FI972495A0 (fi) Menetelmä orgaanisia yhdisteitä hajottavien mikroorganismien valmistamiseksi
EE9800430A (et) Uued ühendid
ID17561A (id) Komposisi untuk pemakaian luar
DE69532558D1 (de) Chelatverbindungen
FI970151A0 (fi) Viruksenvastaisesti vaikuttavia difluoristatoniyhdisteitä
DE69709659D1 (de) Halopropargyl-einschlussverbindungen
BR9509740A (pt) Compostos 18-nor-vitamina d
DE69523450T2 (de) Inhibitor
EE9900012A (et) Uudsed ühendid
FI963509A0 (fi) Isoksatsoliiniyhdisteitä 5-lipoksigenaasi-inhibiittoreina
ATE232532T1 (de) Trizyclische carbapenem-verbindungen
BR9506516A (pt) Oxazolinas substituídas
KR950025986U (ko) 스리브 카바
SE9400968D0 (sv) Heterocyclic compounds
SE9402122D0 (sv) Heterocyclic compounds
SE9404416D0 (sv) Novel compounds
SE9402813D0 (sv) New compounds
SE9402838D0 (sv) New compounds
SE9403728D0 (sv) New compounds